BDSX vs BK · rev $52.4M vs P/E 17, $94.14B cap
Biodesix Inc (BDSX) versus The Bank of New York Mellon Corporation (BK) — a side-by-side from cached financials, not a winner call.
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Latest reported BDSX revenue for 2026-06-30 was $52.4M. Net income was -$15.1M. BDSX currently screens at market cap $157.6M.
BK does not have a complete income-statement cache yet.
BDSX currently screens at market cap $157.6M. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Not investment advice. Open the BDSX and BK stock pages for the full models.
Not investment advice.